Correlation of plasma levels of a potential biomarker (CK-18) with diarrhea in dogs with mast cell tumor treated receiving toceranib (Palladia). -- The purpose of this pilot study is to determine if plasma CK18 levels can be used as a biomarker that can predict GI side effects in dogs receiving toceranib.
Evaluation of Allergenic Extract Intradermal Threshold Concentration Variation in Non-Allergic Dogs. -- The purpose of this study is to establish threshold concentrations of allergens by a new veterinary allergen company.
Effect of a probiotic bacterium in dogs with Inflammatory Bowel Disease. -- This study aims to measure the effect of a probiotic (Akkermansia muciniphila) on intestinal permeability, inflammation, and GLP-2 secretion in with naturally occurring IBD that failed conventional treatments (other than immunosuppressive drugs).